These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Relation of factor VIII and IX inhibitors with ABO blood groups in 150 patients with haemophilia A and B. Torghabeh HM, Pourfathollah A, Shooshtari MM, Yazdi ZR. Iran J Allergy Asthma Immunol; 2006 Mar; 5(1):33-4. PubMed ID: 17242502 [Abstract] [Full Text] [Related]
13. Defining severity of hemophilia: more than factor levels. Pavlova A, Oldenburg J. Semin Thromb Hemost; 2013 Oct; 39(7):702-10. PubMed ID: 24026911 [Abstract] [Full Text] [Related]
14. [Hemophiliacs with inhibitor. Experience at the Center of Medical Action for Hemophilia of the S. José Hospital]. Diniz MJ, Dias Francisco F, Tavares ML, Leal I. Acta Med Port; 1992 Apr; 5(4):178-80. PubMed ID: 1605065 [Abstract] [Full Text] [Related]
15. [Comparison of modified Bethesda assay and Nijmegen assay in detecting FVII inhibitor in patients with hemophilia A]. Fan LK, Wang ZW, Hua BL, Su W, Wang SJ, Zhao YQ. Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Oct; 31(5):551-4. PubMed ID: 19968068 [Abstract] [Full Text] [Related]
16. [Prophylaxis in patients with haemophilia complicated by inhibitors]. Paweł Ł. Pol Merkur Lekarski; 2011 Mar; 30(177):211-4. PubMed ID: 21545000 [Abstract] [Full Text] [Related]
20. The rapid Bethesda assay is equivalent to the standard Bethesda assay for detection of factor IX inhibitors in patients with severe haemophilia B. Sahud M, Zhukov O, Naides SJ, Serrano C, Wong E, Dlott J, Racke F. Haemophilia; 2020 Jul; 26(4):735-740. PubMed ID: 32420682 [Abstract] [Full Text] [Related] Page: [Next] [New Search]